NO803790L - Fremgangsmaate til fremstilling av substituerte fenylpyridiner - Google Patents

Fremgangsmaate til fremstilling av substituerte fenylpyridiner

Info

Publication number: NO803790L
Authority: NO; Norway
Prior art keywords: pyridine; acid; dihydroxyphenyl; salt; preparation
Prior art date: 1979-12-20

Application number

NO803790A

Other languages

English (en)

Norwegian (no)

Inventor

Joseph Charles Collins

George Yohe Lesher

Baldev Singh

Original Assignee

Sterling Drug Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-12-20

Filing date

1980-12-16

Publication date

1981-06-22

1980-12-16 Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc

1981-06-22 Publication of NO803790L publication Critical patent/NO803790L/no

Links

238000002360 preparation method Methods 0.000 title claims description 22
238000000034 method Methods 0.000 title claims description 12
150000005359 phenylpyridines Chemical class 0.000 title description 2
150000003839 salts Chemical class 0.000 claims description 34
JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 29
239000002253 acid Substances 0.000 claims description 25
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 17
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 14
239000012458 free base Substances 0.000 claims description 11
-1 pyridine compound Chemical class 0.000 claims description 10
VQSAZLNDWODBDE-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)pyridine Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC=NC=C1 VQSAZLNDWODBDE-UHFFFAOYSA-N 0.000 claims description 6
229910000042 hydrogen bromide Inorganic materials 0.000 claims description 6
239000012649 demethylating agent Substances 0.000 claims description 4
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
239000000203 mixture Substances 0.000 description 15
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
239000000243 solution Substances 0.000 description 10
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
230000000747 cardiac effect Effects 0.000 description 9
GQRZBBQWBHAPOX-UHFFFAOYSA-N chembl110377 Chemical compound C1=C(O)C(O)=CC=C1C1=CC=NC=C1 GQRZBBQWBHAPOX-UHFFFAOYSA-N 0.000 description 9
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
IEKUOGMAQGDLBI-UHFFFAOYSA-N 4-pyridin-3-ylbenzene-1,2-diol Chemical compound C1=C(O)C(O)=CC=C1C1=CC=CN=C1 IEKUOGMAQGDLBI-UHFFFAOYSA-N 0.000 description 8
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 8
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
239000007864 aqueous solution Substances 0.000 description 6
GDTGFWRUXZQNHK-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)pyridine Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC=CC=N1 GDTGFWRUXZQNHK-UHFFFAOYSA-N 0.000 description 5
150000001875 compounds Chemical class 0.000 description 5
230000000694 effects Effects 0.000 description 5
238000001704 evaporation Methods 0.000 description 5
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
230000008020 evaporation Effects 0.000 description 4
229910052739 hydrogen Inorganic materials 0.000 description 4
239000001257 hydrogen Substances 0.000 description 4
125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
239000003701 inert diluent Substances 0.000 description 4
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
239000007787 solid Substances 0.000 description 4
JYVKXDCHFCZGTQ-UHFFFAOYSA-N 3-(3,4-dimethoxyphenyl)pyridine Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC=CN=C1 JYVKXDCHFCZGTQ-UHFFFAOYSA-N 0.000 description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 3
229910019142 PO4 Inorganic materials 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
229910000147 aluminium phosphate Inorganic materials 0.000 description 3
230000003177 cardiotonic effect Effects 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
229940098779 methanesulfonic acid Drugs 0.000 description 3
210000003540 papillary muscle Anatomy 0.000 description 3
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
239000010452 phosphate Substances 0.000 description 3
239000002244 precipitate Substances 0.000 description 3
238000010992 reflux Methods 0.000 description 3
239000000725 suspension Substances 0.000 description 3
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
241000282472 Canis lupus familiaris Species 0.000 description 2
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
241000282326 Felis catus Species 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
150000001450 anions Chemical class 0.000 description 2
230000001746 atrial effect Effects 0.000 description 2
150000007514 bases Chemical class 0.000 description 2
230000036772 blood pressure Effects 0.000 description 2
ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
239000000496 cardiotonic agent Substances 0.000 description 2
239000003610 charcoal Substances 0.000 description 2
238000001816 cooling Methods 0.000 description 2
HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 2
239000003937 drug carrier Substances 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
238000001914 filtration Methods 0.000 description 2
210000002837 heart atrium Anatomy 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
239000004310 lactic acid Substances 0.000 description 2
235000014655 lactic acid Nutrition 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
239000003960 organic solvent Substances 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
239000000047 product Substances 0.000 description 2
AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 2
229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
235000017557 sodium bicarbonate Nutrition 0.000 description 2
LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
239000002904 solvent Substances 0.000 description 2
238000003756 stirring Methods 0.000 description 2
239000000126 substance Substances 0.000 description 2
238000010998 test method Methods 0.000 description 2
238000009736 wetting Methods 0.000 description 2
239000000080 wetting agent Substances 0.000 description 2
AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 1
CQVKMVQRSNNAGO-UHFFFAOYSA-N 2-[4-formyl-3-methyl-n-(2-methylsulfonyloxyethyl)anilino]ethyl methanesulfonate Chemical compound CC1=CC(N(CCOS(C)(=O)=O)CCOS(C)(=O)=O)=CC=C1C=O CQVKMVQRSNNAGO-UHFFFAOYSA-N 0.000 description 1
LGDHZCLREKIGKJ-UHFFFAOYSA-N 3,4-dimethoxyaniline Chemical compound COC1=CC=C(N)C=C1OC LGDHZCLREKIGKJ-UHFFFAOYSA-N 0.000 description 1
SASRAULNUTVBER-UHFFFAOYSA-N 3-(3,4-dimethoxyphenyl)pyridine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1C1=CC=CN=C1 SASRAULNUTVBER-UHFFFAOYSA-N 0.000 description 1
PHCYRGIPHDLGCF-UHFFFAOYSA-N 3-pyridin-4-ylphenol Chemical compound OC1=CC=CC(C=2C=CN=CC=2)=C1 PHCYRGIPHDLGCF-UHFFFAOYSA-N 0.000 description 1
UIBXPXGTKDXQPE-UHFFFAOYSA-N 4-(1-methylpyridin-1-ium-4-yl)benzene-1,2-diol;chloride Chemical compound [Cl-].C1=C[N+](C)=CC=C1C1=CC=C(O)C(O)=C1 UIBXPXGTKDXQPE-UHFFFAOYSA-N 0.000 description 1
FCZSNZVQFATWQP-UHFFFAOYSA-N 4-(1-methylpyridin-1-ium-4-yl)benzene-1,2-diol;iodide Chemical compound [I-].C1=C[N+](C)=CC=C1C1=CC=C(O)C(O)=C1 FCZSNZVQFATWQP-UHFFFAOYSA-N 0.000 description 1
SRBKDAPOUTZZLA-UHFFFAOYSA-M 4-(3,4-dimethoxyphenyl)-1-methylpyridin-1-ium;iodide Chemical compound [I-].C1=C(OC)C(OC)=CC=C1C1=CC=[N+](C)C=C1 SRBKDAPOUTZZLA-UHFFFAOYSA-M 0.000 description 1
DFMXRNVIQGHUJY-UHFFFAOYSA-N 4-(pyridin-2-ylmethyl)benzene-1,2-diol Chemical compound C1=C(O)C(O)=CC=C1CC1=CC=CC=N1 DFMXRNVIQGHUJY-UHFFFAOYSA-N 0.000 description 1
QFNGZNQJAAQOHM-UHFFFAOYSA-N 4-pyridin-4-ylbenzene-1,2-diol hydrobromide Chemical compound Br.C1=C(O)C(O)=CC=C1C1=CC=NC=C1 QFNGZNQJAAQOHM-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
NFPHMABMGIUHEH-UHFFFAOYSA-N Br.COC=1C=C(C=CC1OC)C=1C=NC=CC1 Chemical compound Br.COC=1C=C(C=CC1OC)C=1C=NC=CC1 NFPHMABMGIUHEH-UHFFFAOYSA-N 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 1
LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
229910021607 Silver chloride Inorganic materials 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
230000003276 anti-hypertensive effect Effects 0.000 description 1
210000003192 autonomic ganglia Anatomy 0.000 description 1
239000002585 base Substances 0.000 description 1
SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
229940077388 benzenesulfonate Drugs 0.000 description 1
SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
229940092714 benzenesulfonic acid Drugs 0.000 description 1
229910000019 calcium carbonate Inorganic materials 0.000 description 1
239000002775 capsule Substances 0.000 description 1
210000000748 cardiovascular system Anatomy 0.000 description 1
RSMISMNEGXNLRF-UHFFFAOYSA-N chembl458334 Chemical compound C1=C(O)C(O)=CC=C1C1=CC=CC=N1 RSMISMNEGXNLRF-UHFFFAOYSA-N 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
239000007891 compressed tablet Substances 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
238000001035 drying Methods 0.000 description 1
238000000921 elemental analysis Methods 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
230000001804 emulsifying effect Effects 0.000 description 1
ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 1
LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
229940093471 ethyl oleate Drugs 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
239000011521 glass Substances 0.000 description 1
239000008187 granular material Substances 0.000 description 1
XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
229910000043 hydrogen iodide Inorganic materials 0.000 description 1
ILVUABTVETXVMV-UHFFFAOYSA-N hydron;bromide;iodide Chemical compound Br.I ILVUABTVETXVMV-UHFFFAOYSA-N 0.000 description 1
238000002329 infrared spectrum Methods 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
239000008101 lactose Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
229940057995 liquid paraffin Drugs 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
238000001819 mass spectrum Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
239000011707 mineral Substances 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
230000037230 mobility Effects 0.000 description 1
239000012452 mother liquor Substances 0.000 description 1
LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
210000000653 nervous system Anatomy 0.000 description 1
238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
235000008390 olive oil Nutrition 0.000 description 1
239000004006 olive oil Substances 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
150000002895 organic esters Chemical class 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
239000002304 perfume Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
239000006187 pill Substances 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
239000000843 powder Substances 0.000 description 1
238000000746 purification Methods 0.000 description 1
ZHNFLHYOFXQIOW-LPYZJUEESA-N quinine sulfate dihydrate Chemical compound [H+].[H+].O.O.[O-]S([O-])(=O)=O.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 ZHNFLHYOFXQIOW-LPYZJUEESA-N 0.000 description 1
239000000376 reactant Substances 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
235000010288 sodium nitrite Nutrition 0.000 description 1
230000003019 stabilising effect Effects 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000008223 sterile water Substances 0.000 description 1
239000003206 sterilizing agent Substances 0.000 description 1
239000012258 stirred mixture Substances 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
IIACRCGMVDHOTQ-UHFFFAOYSA-M sulfamate Chemical compound NS([O-])(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-M 0.000 description 1
239000000375 suspending agent Substances 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
229940095064 tartrate Drugs 0.000 description 1
238000002211 ultraviolet spectrum Methods 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

NO803790A 1979-12-20 1980-12-16 Fremgangsmaate til fremstilling av substituerte fenylpyridiner NO803790L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US10585179A	1979-12-20	1979-12-20

Publications (1)

Publication Number	Publication Date
NO803790L true NO803790L (no)	1981-06-22

Family

ID=22308136

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO803790A NO803790L (no)	1979-12-20	1980-12-16	Fremgangsmaate til fremstilling av substituerte fenylpyridiner

Country Status (22)

Country	Link
JP (1)	JPS56118064A (fr)
KR (1)	KR830004249A (fr)
AR (1)	AR226442A1 (fr)
AT (1)	AT374459B (fr)
AU (1)	AU6515880A (fr)
BE (1)	BE886675A (fr)
DE (1)	DE3047615A1 (fr)
DK (1)	DK536680A (fr)
ES (1)	ES497787A0 (fr)
FI (1)	FI803913L (fr)
FR (1)	FR2471976A1 (fr)
GB (1)	GB2065651B (fr)
IL (1)	IL61676A (fr)
IT (1)	IT1194006B (fr)
LU (1)	LU83007A1 (fr)
NL (1)	NL8006785A (fr)
NO (1)	NO803790L (fr)
NZ (1)	NZ195758A (fr)
PH (1)	PH16466A (fr)
PT (1)	PT72206B (fr)
SE (1)	SE8008887L (fr)
ZA (1)	ZA807781B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5502050A (en) *	1993-11-29	1996-03-26	Cornell Research Foundation, Inc.	Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1183046A (en) *	1966-06-28	1970-03-04	Allen & Hanburys Ltd	Novel Heterocyclic Compounds

1980
- 1980-12-04 NZ NZ195758A patent/NZ195758A/en unknown
- 1980-12-08 AU AU65158/80A patent/AU6515880A/en not_active Abandoned
- 1980-12-09 IL IL61676A patent/IL61676A/xx unknown
- 1980-12-12 ZA ZA00807781A patent/ZA807781B/xx unknown
- 1980-12-15 FI FI803913A patent/FI803913L/fi not_active Application Discontinuation
- 1980-12-15 NL NL8006785A patent/NL8006785A/nl not_active Application Discontinuation
- 1980-12-15 GB GB8040121A patent/GB2065651B/en not_active Expired
- 1980-12-15 IT IT26661/80A patent/IT1194006B/it active
- 1980-12-16 FR FR8026689A patent/FR2471976A1/fr not_active Withdrawn
- 1980-12-16 AT AT0613180A patent/AT374459B/de not_active IP Right Cessation
- 1980-12-16 LU LU83007A patent/LU83007A1/fr unknown
- 1980-12-16 NO NO803790A patent/NO803790L/no unknown
- 1980-12-16 ES ES497787A patent/ES497787A0/es active Granted
- 1980-12-16 PT PT72206A patent/PT72206B/pt unknown
- 1980-12-16 BE BE1/10076A patent/BE886675A/fr not_active IP Right Cessation
- 1980-12-17 DE DE19803047615 patent/DE3047615A1/de not_active Withdrawn
- 1980-12-17 DK DK536680A patent/DK536680A/da unknown
- 1980-12-17 KR KR1019800004813A patent/KR830004249A/ko unknown
- 1980-12-17 JP JP17867080A patent/JPS56118064A/ja active Pending
- 1980-12-17 AR AR283675A patent/AR226442A1/es active
- 1980-12-17 SE SE8008887A patent/SE8008887L/xx not_active Application Discontinuation
- 1980-12-18 PH PH25004A patent/PH16466A/en unknown

Also Published As

Publication number	Publication date
DE3047615A1 (de)	1981-09-17
IT1194006B (it)	1988-08-31
ATA613180A (de)	1983-09-15
NL8006785A (nl)	1981-07-16
GB2065651B (en)	1983-10-05
JPS56118064A (en)	1981-09-16
IL61676A (en)	1984-02-29
DK536680A (da)	1981-06-21
IT8026661A0 (it)	1980-12-15
AU6515880A (en)	1981-06-25
KR830004249A (ko)	1983-07-09
GB2065651A (en)	1981-07-01
SE8008887L (sv)	1981-06-21
ZA807781B (en)	1981-12-30
FI803913L (fi)	1981-06-21
PT72206B (en)	1981-10-28
BE886675A (fr)	1981-06-16
AR226442A1 (es)	1982-07-15
NZ195758A (en)	1984-07-06
PH16466A (en)	1983-10-20
LU83007A1 (fr)	1981-07-23
AT374459B (de)	1984-04-25
FR2471976A1 (fr)	1981-06-26
ES8200872A1 (es)	1981-11-16
ES497787A0 (es)	1981-11-16
PT72206A (en)	1981-01-01
IL61676A0 (en)	1981-01-30

Publication	Publication Date	Title
NO144455B (no)	1981-05-25	Fremgangsmaate ved fremstilling av terapeutisk aktive nye piperidinderivater
US4465686A (en)	1984-08-14	5-(Hydroxy- and/or amino-phenyl)-6-(lower-alkyl)-2-(1H)-pyridinones, their cardiotonic use and preparation
US4304777A (en)	1981-12-08	6-(Pyridinyl)-3(2H)-pyridazinones and their use as cardiotonics
US4302462A (en)	1981-11-24	4(or 3)-(3,4-Dihydroxyphenyl)pyridines, their cardiotonic use and cardiotonic use of their methyl ethers
US4599423A (en)	1986-07-08	Preparation of 5-(hydroxy- and/or aminophenyl-6-lower-alkyl)-2(1H)-pyridinones
NO851066L (no)	1985-03-18	Pyridinyl-2-pyrimidinaminer egnet som kardiotoniske midler samt fremstilling derav
NO803790L (no)	1981-06-22	Fremgangsmaate til fremstilling av substituerte fenylpyridiner
NO803911L (no)	1981-06-29	3-acylamino-5-(pyridinyl)-2(1h)-pyridinoner og fremgangsmaate til fremstilling derav
CA1161440A (fr)	1984-01-31	4-[4(ou 3)-acylaminophenyl] pyridines, leur preparation et leur utilisation comme agents cardiotoniques
US4463008A (en)	1984-07-31	2-Alkoxy-5-(pyridinyl)pyridines and cardiotonic use thereof
US4305943A (en)	1981-12-15	4-Amino-6-(pyridinyl)-3(2H)-pyridazinones and their use as cardiotonics
EP1927591A1 (fr)	2008-06-04	Formes polymorphes de deferasirox (ICL670)
US4225601A (en)	1980-09-30	3-Hydroxy or hydroxymethyl-5-(4-pyridinyl)2(1H)-pyridinones, useful as cardiotonic agents and their preparation
US4346221A (en)	1982-08-24	Preparation of 4-amino-6-(pyridinyl)-3(2H)-pyridazinones from 6-(pyridinyl)-3(2H)-pyridazinones
US4304776A (en)	1981-12-08	4-Substituted-6-(pyridinyl)-3(2h)-pyridazinones and their use as intermediates and cardiotonics
US4473571A (en)	1984-09-25	8-Substituted-2-(4-pyridinyl)-9H-purin-6-amines and their cardiotonic use
US4376775A (en)	1983-03-15	N-[4-(4-Pyridinyl)phenyl]ureas and their cardiotonic use
US4590194A (en)	1986-05-20	3-[methyl or dimethyl)amino]-6-(pyridinyl)pyridazines and their cardiotonic use
NO803735L (no)	1981-06-15	6-(pyridinyl)pyridaziner og fremgangsmaate til deres fremstilling
US4362735A (en)	1982-12-07	3-[(3-Oxo-1-butenyl)amino]-5-(pyridinyl)-2(1H)-pyridinones and their cardiotonic use
US4338446A (en)	1982-07-06	Di-(lower-alkyl)hydroxy-[2-oxo-2-(pyridinyl)ethyl]-propanedioates
US4354026A (en)	1982-10-12	3-Chloro-6-(pyridinyl)-pyridazines
NO135590B (fr)	1977-01-17
US4377585A (en)	1983-03-22	Use of 4-[4(or 3)-aminophenyl]pyridines as cardiotonic agents
US4361569A (en)	1982-11-30	3-(Hydroxy or hydroxymethyl)-6-methyl-5-(4-pyridinyl)-2(1H)-pyridinone and cardiotonic use thereof